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Abstract
Effects of polyomavirus SV40 microRNA on pathogenesis of viral infections in vivo are not known. Syrian golden hamsters
are the small animal model for studies of SV40. We report here effects of SV40 microRNA and influence of the structure of
the regulatory region on dynamics of SV40 DNA levels in vivo. Outbred young adult hamsters were inoculated by the
intracardiac route with 16107 plaque-forming units of four different variants of SV40. Infected animals were sacrificed from
3 to 270 days postinfection and viral DNA loads in different tissues determined by quantitative real-time polymerase chain
reaction assays. All SV40 strains displayed frequent establishment of persistent infections and slow viral clearance. SV40 had
a broad tissue tropism, with infected tissues including liver, kidney, spleen, lung, and brain. Liver and kidney contained
higher viral DNA loads than other tissues; kidneys were the preferred site for long-term persistent infection although
detectable virus was also retained in livers. Expression of SV40 microRNA was demonstrated in wild-type SV40-infected
tissues. MicroRNA-negative mutant viruses consistently produced higher viral DNA loads than wild-type SV40 in both liver
and kidney. Viruses with complex regulatory regions displayed modestly higher viral DNA loads in the kidney than those
with simple regulatory regions. Early viral transcripts were detected at higher levels than late transcripts in liver and kidney.
Infectious virus was detected infrequently. There was limited evidence of increased clearance of microRNA-deficient viruses.
Wild-type and microRNA-negative mutants of SV40 showed similar rates of transformation of mouse cells in vitro and tumor
induction in weanling hamsters in vivo. This report identified broad tissue tropism for SV40 in vivo in hamsters and provides
the first evidence of expression and function of SV40 microRNA in vivo. Viral microRNA dampened viral DNA levels in tissues
infected by SV40 strains with simple or complex regulatory regions.
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Introduction
Definition of steps in the pathogenesis of a viral infection and of
the response of the host to the viral assault is important to
understanding the genesis of associated diseases and to guiding the
development of viral diagnostics, therapeutics, and preventative
measures. Viral microRNAs (miRNAs) are predicted to be
involved in the infection process.
Polyomaviruses are small, nonenveloped, DNA-containing
viruses that establish persistent infections in susceptible hosts and
induce tumors under certain conditions. The Polyomaviridae
family contains several viral species able to infect humans, some of
which have been linked with disease, especially in immunocom-
promised hosts. Little is known of the patterns and dynamics of
acute and chronic infections by polyomaviruses in vivo, except that
kidneys appear to be a common site of long-term persistence [1].
Simian virus 40 (SV40) is the type species of the virus family.
Since its discovery in 1960, it has served as a model cancer virus
and has revealed many insights into fundamental cell processes
and basic mechanisms of cell transformation [2–8]. SV40, whose
natural host is the rhesus macaque monkey, is able to infect
humans. It is currently the only polyomavirus that can infect
humans that has a small animal model amenable to mechanistic
studies of early steps in viral pathogenesis. Syrian golden hamsters
(Mesocricetus auratus) have been widely utilized for studies of SV40
infections and oncogenesis [9–17]. It has been shown that SV40
isolates differ in oncogenic potential in vivo, with those having a
regulatory region (RR) with a single enhancer region being more
oncogenic in weanling hamsters than those with a complex,
rearranged RR. These RR differences, however, had no effect on
transforming frequencies in vitro, suggesting that differences in
tumor induction reflected viral interactions with the host [16].
Conversely, vertical transmission of virus from pregnant dams to
their offspring was more frequent when infections involved an
SV40 strain with a complex RR [15]. In addition, viruses with a
complex RR induce more frequent antibody responses to the
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SV40 large T-antigen (T-ag) in tumor-free animals than those with
a simple RR following intraperitoneal inoculation [10,16]. We
interpret these observations as indications that viruses with
complex RR replicated better in vivo, increasing the likelihood of
vertical transmission and of elevated synthesis of T-ag, the latter
leading to more detectable T-antibody responses. Despite these
findings, the effect of viral genetic variation among virus strains on
the natural history of acute and persistent infections is not known.
miRNAs are small, noncoding RNAs that are key regulators of
gene expression, able to control large networks of genes by binding
and repressing mRNAs; miRNAs can regulate cell cycle genes and
host response genes, modulate downstream gene expression, and
play a role in tumorigenesis [18,19]. SV40, the first polyomavirus
found to encode viral miRNAs, expresses a precursor miRNA
giving rise to two derivative effectors during infection in cultured
cells. Both SV40 miRNA effectors (5p and 3p) reduce expression
of the viral early proteins [20]. The presence or absence of viral
miRNA appeared to have no effect on replication of the virus in
tissue culture, although there were higher levels of T-ag in mutant-
infected cells, and it was proposed that the miRNAs might
function in vivo to help infected cells avoid killing by the host
immune response. To date, no animal studies addressing SV40
miRNA function in vivo have been reported.
This project was undertaken to characterize patterns of acute
and chronic infections by polyomavirus SV40 in a susceptible host.
Specific objectives were (i) to identify tissues that can be infected by
SV40 and those that are sites of long-term persistence, (ii) to
measure quantitative changes in viral DNA levels over time in
different tissues, (iii) to determine if SV40 genetic differences,
including the presence of viral miRNA and the structure of the
viral RR, affect the patterns of infections in vivo, and (iv) to evaluate
the influence of viral miRNA on tumor induction.
Results
Frequent establishment of persistent infections by SV40
Young adult, outbred Syrian golden hamsters were inoculated
by the intracardiac route with 16107 plaque-forming units (PFU)
of two wild-type (WT) strains of SV40, one having a complex (2E)
RR (776-WT) (GenBank accession No. J02400) and one a simple
archetypal (1E) RR (SVCPC-WT) (GenBank accession
No. AF156108), and with mutants unable to produce SV40
miRNAs derived from each WT strain (776-SM1, SVCPC-SM2).
The intracardiac route of inoculation was used to distribute the
virus throughout the body in order to identify susceptible tissues.
Animals were sacrificed at times ranging from 3 to 270 days
postinoculation (p.i.), organs were harvested, and the presence of
SV40 DNA was determined by real-time quantitative polymerase
chain reaction (RQ-PCR) assays as detailed in Materials and
Methods. The total numbers of tissues analyzed and the
percentages that were positive for detectable levels of viral DNA
are summarized (Table 1). All four viruses were efficient at
establishing persistent infections. Animals were frequently virus-
positive in liver, kidney, and spleen through day 45 and in kidney
through day 270. In fact, all the liver and kidney samples collected
through day 45 from infected animals were virus positive with only
two exceptions. Spleen, lung and brain less commonly contained
detectable viral DNA and virus disappeared more quickly. Muscle
and cheek pouch specimens from 15 animals inoculated with the
776 viruses were tested at days 3, 7, and 45 p.i. and all were
negative for viral DNA (data not shown).
Polyomaviruses are known to establish persistent infections and
these results illustrate the highly efficient nature of the process by
SV40 (Table 1). At this level of analysis in which tissue samples
were either positive or negative for viral DNA, no obvious effect of
viral miRNA or the viral RR on the dynamics of viral presence in
different tissues could be discerned.
Distribution of viral loads among infected animals and
tissues
Viral DNA levels in hamster tissues were quantitated using an
SV40-specific RQ-PCR assay. The single-copy hamster vimentin
gene (GenBank accession No. AH001833.1) was also measured by
RQ-PCR to determine the number of cell equivalents of DNA in
tissue extracts; viral loads were then expressed as SV40 DNA
copies per 104 cells. Observed viral loads (log2) in liver and kidney
samples from individual animals are shown for each of the four
viruses (Figure 1). Geometric mean values for each set of
experimental animals are represented by horizontal lines.
Decreases in viral loads tended to occur between days 14 and
28 with all four viruses, although viral DNA remained readily
detectable. There was often a range in viral loads among the
animals within a virus group harvested at each time point,
presumably reflecting at least in part individual variation typical of
outbred animals.
The relative amounts of virus found in liver, kidney, spleen,
lung, and brain early during infection (days 7 and 14) are shown
(Table 2). Data for the four viruses are presented as averages of
observed values (SV40 DNA copies/104 cells). During the early
stages of infection SV40 viral loads were higher in liver and kidney
than the other tissues with all the viruses, ranging from several fold
to 100-fold in excess. Higher levels of SV40 DNA copies were
usually detected with the miRNA-negative mutants than with the
WT viruses in the liver and kidney samples. This difference was
observed despite the fact that fewer viral genome copies were
inoculated per 107 PFU with the mutant viruses than with the WT
strains (Materials and Methods). There was a trend for viral loads
of WT viruses to increase between days 7 and 14 in liver and
kidney, in contrast to decreases in viral loads of the miRNA
mutant viruses in most cases. Subsequent detailed analyses focused
on liver and kidney specimens.
Persistence of viral DNA in hamster kidney following
SV40 infections
Analysis of viral load data over time quantitated the preferential
persistence of SV40 in the kidney compared to the liver and
Author Summary
The recent discovery of virally encoded microRNAs
(miRNAs) raises the possibility of additional regulatory
processes being involved in viral replication, immune
recognition, and host cell survival. In this study, we sought
to characterize the effect of SV40-encoded miRNAs and
the structure of the viral regulatory region on infections in
outbred Syrian golden hamsters. Results revealed that
SV40 has a wide tissue tropism, including liver, kidney,
spleen, lung, and brain, with kidney the preferred site for
long-term persistent infection. Significant increases in
tissue-associated viral DNA loads were observed with
miRNA-negative mutant strains, whereas the presence of
SV40 miRNAs had no effect on tumor induction and little
effect on viral clearance. Our results provide the first
evidence for SV40 miRNA expression and function in an in
vivo animal model and highlight the complexity of
regulation of SV40 viral replication and persistent infec-
tions.
SV40 MicroRNA Effects in Hamsters
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spleen. Virus levels, expressed as a ratio of day 45 to day 3 values
for each virus (SV40 DNA copies/104 cells), are shown (Table 3).
Between 0.41 and 1.29 of day 3 levels were detected at day 45 in
kidneys (equivalent to 41% and 129% of day 3 levels), in contrast
to ratios of 0.10 to 0.17 in livers and even smaller ratios (#0.10) in
spleen. These day 45:day 3 ratios show a higher relative
persistence of SV40 in kidney than in liver by day 45 p.i. with
all four viruses. The ratios of viral DNA levels in kidney:liver and
in kidney:spleen at each time point are detailed in supplemental
information (Table S1). These data suggest there was a
reproducible trend for long-term viral persistence in the kidney,
consistent with the idea that the kidney is the major reservoir for
persistent infections in natural hosts by the well-characterized
polyomaviruses. However, the retention of detectable viral DNA
in the liver suggests that cells in the liver may be an unrecognized
site of persistent infection by SV40 (Table 3). We noted there was
a higher viral load ratio for 776-WT virus in kidney relative to
SVCPC-WT virus (approximately 1.5-fold higher) as well as a
higher ratio for the two miRNA mutants in kidney compared to
the respective parental WT virus (about 2-fold higher) (Table 3).
These results suggest that both a complex RR and the absence of
viral miRNA can lead to higher chronic levels of SV40 viral DNA
in the kidney of susceptible hosts. Virus was frequently detected in
the kidney at day 270, ranging from 62% to 100% of animals
tested (Table 1). However, only occasional animals (0–43%) had
detectable virus remaining in the liver at day 270, and it is
noteworthy that the 776 miRNA mutant (776-SM1) was not
detected.
Expression of SV40 miRNA in hamster tissues
The expression of the SV40 miRNA in hamster liver and kidney
tissues was analyzed as described in Materials and Methods.
Briefly, total RNA was harvested and then size-fractionated to
enrich for small RNAs. The presence of the SV40 3p miRNA was
determined via RT-PCR. Specimens were coded and tested
without knowledge of sample identity. A sample was scored
positive if its CT was #35, which is within the linear range of this
assay (as determined using a standard dilution series).
Expression of SV40 miRNA was detected in tissue samples from
animals infected with WT SV40 strains, but not in tissues infected
with miRNA-negative mutants (Table 4). Compared to cultured
African green monkey BSC40 cells infected with SV40 at a high
multiplicity of infection (MOI) (CT 12.2), or to an abundant host
miRNA in BSC40 cells (miR-Let7a, CT 24.6), the levels of the
SV40 miRNA in hamsters were lower (CT 31–,35); likely
reflective of the fact that only a small fraction of the assayed cells
was infected. Twelve of 15 (80%) WT-infected samples tested
positive for SV40 miRNA, including 7 of 7 (100%) kidney
Table 1. Frequent persistence of SV40 in hamster tissues following intracardiac inoculation.
Virus
Encode SV40
microRNA Days p.i. No. animals with SV40-positive tissues/No. tested (%)
a
Liver Kidney Spleen Lung Brain
776-WT + 3 4/4 (100) 4/4 (100) 4/4 (100) 4/4 (100) 2/4 (50)
7 3/3 (100) 3/3 (100) 2/2 (100) 3/3 (100) 0/3 (0)
14 4/4 (100) 4/4 (100) 2/4 (50) 0/3 (0) 0/4 (0)
28 3/4 (75) 4/4 (100) 0/4 (0) 0/4 (0) 0/4 (0)
45 3/3 (100) 3/3 (100) ND 0/3 (0) 0/3 (0)
270 3/7 (43) 6/7 (86) ND ND ND
776-SM1 0 3 4/4 (100) 4/4 (100) 3/4 (75) 3/4 (75) 1/4 (25)
7 4/4 (100) 4/4 (100) 4/4 (100) 1/4 (25) 1/4 (25)
14 4/4 (100) 4/4 (100) 3/4 (100) 0/4 (0) 0/4 (0)
28 4/4 (100) 4/4 (100) 0/3 (0) ND 0/3 (0)
45 3/3 (100) 4/4 (100) 2/4 (50) 1/4 (25) 0/3 (0)
270 0/9 (0) 5/8 (62) ND ND ND
SVCPC-WT + 3 4/4 (100) 4/4 (100) 4/4 (100) 4/4 (100) 3/3 (100)
7 4/4 (100) 4/4 (100) 4/4 (100) 1/4 (25) 0/3 (0)
14 4/4 (100) 4/4 (100) 4/4 (100) 1/4 (25) 1/3 (33)
28 4/4 (100) 4/4 (100) 4/4 (100) 0/4 (0) 1/3 (33)
45 4/4 (100) 4/4 (100) 3/4 (75) 1/4 (25) ND
270 1/6 (17) 5/6 (83) ND ND ND
SVCPC-SM2 0 3 4/4 (100) 4/4 (100) 4/4 (100) 4/4 (100) 3/4 (75)
7 4/4 (100) 4/4 (100) 3/3 (100) 4/4 (100) 1/3 (33)
14 3/3 (100) 2/2 (100) 4/4 (100) 0/3 (0) 1/3 (33)
28 4/4 (100) 3/4 (75) 3/4 (75) 1/4 (25) 0/1 (0)
45 4/4 (100) 4/4 (100) 2/4 (50) 3/4 (75) 0/2 (0)
270 1/6 (17) 8/8 (100) ND ND ND
ND, not done; p.i., postinoculation; SV40, simian virus 40.
aA tissue was considered positive if viral DNA copies were detected by real-time quantitative polymerase chain reaction (described in Materials and Methods).
doi:10.1371/journal.ppat.1003912.t001
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Figure 1. Simian virus 40 viral loads in hamster liver and kidney over time. Observed (nonadjusted) viral DNA copies per 104 cells (log2) are
presented for both liver and kidney specimens from individual animals. The geometric mean for each set of animals is marked by a horizontal line.
Values are shown for days 3 to 45 postinoculation. (A) 776-WT. (B) 776-SM1. (C) SVCPC-WT. (D) SVCPC-SM2.
doi:10.1371/journal.ppat.1003912.g001
Table 2. Viral loads in different hamster tissues during early stages of infection by SV40.
Virus Encode SV40 microRNA Days p.i. Average no. SV40 DNA copies/10
4 cellsa,b,c
Liver Kidney Spleen Lung Brain
776-WT + 7 114 134 26 13 Und
14 299 597 7 4 Und
776-SM1 0 7 1352 235 13 8 209
14 781 250 9 6 Und
SVCPC-WT + 7 206 37 36 37 Und
14 1403 117 20 9 Und
SVCPC-SM2 0 7 1971 437 64 103 6
14 1687 231 19 Und 16
p.i., postinoculation; SV40, simian virus 40; Und, undetectable.
aNumbers represent the average of observed (nonadjusted) results from the tissues analyzed at each time point. See Table 1 for the number of tissues from different
animals tested per virus at each time point (usually n = 4). Two or three separate fragments were assayed and the values averaged from each tissue from each animal
(see Materials and Methods).
bThe inoculum for each virus was 107 plaque-forming units (PFU) per animal by the intracardiac route. The number of SV40 genome DNA copies per PFU varied for each
viral stock: 776-WT, 1700; 776-SM1, 130; SVCPC-WT, 1800; SVCPC-SM2, 590. This resulted in the following ratios of viral genome copies inoculated: 776-WT:776-SM1, 13;
SVCPC-WT:SVCPC-SM2, 3.
cNote that higher viral DNA copy numbers were more often detected in liver and kidney samples from animals exposed to microRNA-negative viruses than in those
infected with wild-type viruses, even though fewer viral genome copies were inoculated with the mutants than with the wild-type viruses. This pattern held for most
specimen collections through day 45 p.i.
doi:10.1371/journal.ppat.1003912.t002
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specimens and 5 of 8 (62%) liver samples. All control samples
tested were negative for SV40 miRNA (0/6, 0%), including 4
miRNA mutant virus-infected tissues and 2 samples from
uninfected hamsters. These results represent the first detection of
SV40 miRNA expression in vivo in intact animals.
SV40 miRNA effects on infection profiles in hamster liver
and kidney
SV40 miRNA effects on the dynamics of SV40 infections in
hamsters were then examined in detail. To directly compare the
infection patterns of paired WT and miRNA-negative mutant
viruses, observed viral genome counts were normalized as
described in Materials and Methods, geometric mean titers were
calculated, and expressed as viral DNA copies (ln) per 10,000 cells
(Figure 2). In the 776 system, the viral loads for the SM1 mutant
were consistently higher than those of the WT virus in both liver
and kidney samples from day 3 through day 45 (Figure 2A). These
differences between the two viruses were statistically significant at
p,0.05 in both tissues at each time point, except for day 3 in the
kidney. Similarly in the SVCPC system, viral DNA levels for the
SM2 miRNA-negative mutant were higher than those of the WT
virus in both liver and kidney from day 3 through day 45
(Figure 2B). The differences between these two viruses in both
tissues were also statistically significant (p,0.05) at each time
point, except for day 7 in the liver.
Viral DNA copies remained detectable at low levels at day 270
in most kidney specimens and less frequently in liver samples
(Tables 1, 5). In contrast to the SVCPC-SM2 miRNA mutant, the
776-SM1 mutant was not detected in the liver of any hamsters
tested at this late time point, suggesting that the SM1 infections
may have been cleared from the liver. The differences in viral
DNA loads at day 270 were statistically significant between the
miRNA mutant and its WT virus in the SVCPC system in both
tissues and between the two miRNA mutants in both tissues
(Table 5). The difference in viral loads between the two WT
viruses in the liver was also statistically significant.
Effect of SV40 miRNA and RR structure on relative viral
levels in hamster tissues
The relative influence of the structure of the SV40 RR and of
the presence or absence of viral miRNA on the dynamics of virus
infection in both liver and kidney was next evaluated (Figure 3).
The bars represent the ratios of the means of normalized viral load
titers between the two viral strains listed below each set; individual
bars within a set reflect days 3 to 270 p.i. The two miRNA-
negative mutants had relatively higher viral DNA loads than the
matched parental WT viruses in the liver, reaching as much as .
100-fold higher (Figure 3A). No bars are shown for day 270 in the
liver for the two comparisons involving the 776-SM1 mutant
because 776-SM1 viral DNA was not detected in the livers of
infected animals at day 270 (Tables 1, 5). The effect in the liver of
the absence of miRNA was more dramatic with the 776 system
than with SVCPC. The mutant viruses also displayed higher viral
DNA loads than the parental WT viruses in kidneys, differences
that reached .20-fold (Figure 3B). The WT and mutant viruses
with complex RR (776-WT, 776-SM1) reached higher viral loads
(#5-fold) in kidney as compared to the viruses with simple RR
(SVCPC-WT, SVCPC-SM2). The loss of viral miRNAs had a
larger impact than the structure of the viral RR on the amount of
viral DNA in infected tissues.
Viral gene expression in liver and kidney tissues
Expression levels of SV40 early (T-ag) and late (VP1) regions in
liver and kidney were determined as described in Materials and
Methods. The single copy hamster vimentin gene was used to
normalize viral transcript levels; results are presented as SV40
Table 3. Preferential persistence of SV40 in kidney compared to liver and spleen.
Virus Encode SV40 microRNA Ratio of day 45:day 3 viral loads (SV40 DNA copies/10
4 cells)a
Kidney Liver Spleen
776-WT + 0.65 0.16 –
776-SM1 0 1.29 0.12 0.10
SVCPC-WT + 0.41 0.10 0.05
SVCPC-SM2 0 0.73 0.17 0.01
SV40, simian virus 40.
aValues represent the ratio of the average observed (nonadjusted) results from day 45 and day 3 for each virus in the indicated tissues. The numbers of tissues from
different animals tested per virus at each time point (usually n = 4) are listed (Table 1). Note the higher level of persistence of each virus in the kidney as compared to
liver and spleen.
doi:10.1371/journal.ppat.1003912.t003
Table 4. Detection of SV40 miRNA in hamster tissuesa.
Virus Days p.i. Tissue
Liver Kidney
776-WT 3 ++
7 +
14 0 ++
28 ++
45 0 ++
776-SM1 14 0 0
SVCPC-WT 3 +, 0
14 +, ++ ++, ++
28 + ++
SVCPC-SM2 3 0
14 0
Control 8 0
270 0
a++, +, 0 = detection of SV40 miRNA with CT35 as cut-off. ++=#32 cycles; +=.
32 to ,35 cycles; 0 =$35 cycles. Each data point represents results for tissue
from one animal. Two results shown for a given type of sample reflect
independent results from two different animals.
doi:10.1371/journal.ppat.1003912.t004
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mRNA copies per 106 vimentin mRNA molecules (Table 6). The
viral early region was expressed at higher levels than the late
region in both liver and kidney samples at time points ranging
from 3 to 45 days p.i. The WT viruses and miRNA-negative
mutants displayed similar expression patterns, with transcript
numbers routinely higher in liver than in kidney. It was noted that
the T-ag mRNA levels from 776-SM1 consistently exceeded those
of the 776-WT virus in the liver. There appeared to be a trend for
T-ag transcript levels in the liver to decrease over time, whereas
those in the kidney increased.
Virus isolation attempts
Recovery of infectious virus was attempted from liver and
kidney specimens from hamsters exposed to the four virus strains.
Tissue lysates were prepared and tested as described in Materials
and Methods. Tissues included kidney samples from animals
sacrificed at 7, 14, 45 and 270 days p.i. and liver samples from
animals harvested at 7 and 14 days p.i. (2 or 3 animals each).
Infectious virus was detected after passage of kidney specimens
collected on day 7 (776-SM1, 3 of 3; SVCPC-SM2, 3 of 3; and
SVCPC-WT, 1 of 2). Other kidney samples were negative and no
Figure 2. Effect of simian virus 40 microRNA on viral loads in hamster liver and kidney over time. (A) Strain 776, wild-type virus and
microRNA-negative mutant SM1. (B) Strain SVCPC, wild-type virus and microRNA-negative mutant SM2. Viral loads are presented as the geometric
mean titers of normalized (adjusted) viral DNA copies (natural log,) per 10,000 cells. The number of different animals analyzed per virus at each time
point (usually n = 4) is shown in Table 1. Viral DNA levels were higher for the two microRNA mutants than for wild-type viruses in both liver and
kidney through day 45. The differences between WT and mutant viruses were statistically significant (p#0.05) for both viral systems in both tissues
(see text for details). Error bars represent the standard deviation.
doi:10.1371/journal.ppat.1003912.g002
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infectious virus was recovered from liver materials tested. These
results suggest that the majority of the viral DNA detected in these
tissues was not present in the form of infectious virus particles by
14 days p.i.
Lack of effect of SV40 miRNA on cell transformation in
vitro
Focus-forming assays using primary mouse embryo fibroblasts
were carried out as described in Materials and Methods to
determine if the absence of SV40 miRNA affected transformation
by the virus in vitro. Three sets of WT and miRNA-negative
mutant viruses were tested, including the 776 and SVCPC strains.
Also tested in the transformation studies were SVCPC-based
recombinants carrying either the 776-WT large T-ag gene
(SVCPC-776-WT) or the T-ag gene with the SM1 mutation
(SVCPC-776-SM1). Replicate infected cultures were harvested
and transformed foci counted at 3 and 5 weeks p.i. For each
matched pair of viruses, numbers of foci were expressed as the
percentage of WT virus transformed foci at 5 weeks (set as 100%).
All six viruses were able to transform mouse cells in vitro (Table 7).
The foci induced by the mutant viruses were somewhat slower
growing and appeared later, but by 5 weeks p.i. there was an
insignificant 2-fold difference in the relative number of foci
produced by the 776-derived mutants. The SVCPC-WT trans-
formed foci were slower at appearing than those induced by the
776-WT viruses, and the SVCPC-SM2-induced foci had a slower
growth rate. Results showed that the lack of miRNA neither
enhanced nor abolished the transforming ability of SV40 in
cultured mouse cells.
Lack of effect of SV40 miRNA on tumor development in
hamsters in vivo
The WT and miRNA mutants were tested for tumor induction
in hamsters to determine if miRNA effects were manifest during in
vivo oncogenesis. Weanling (21-day-old) animals were inoculated
intraperitoneally with 16107 PFU of virus and observed for 12
months. A third pair of viruses (SVCPC-776-WT and SVCPC-
776-SM1) was included in the in vivo tumorigenicity experiment.
All six viruses induced tumor formation. There was no significant
difference in tumor incidence between a given WT virus and its
miRNA-negative mutant for any of the three virus pairs (Table 8).
There was also no difference in the latency period (time to tumors)
between the WT and miRNA mutant viruses. As observed in
earlier studies, virus strains with a simple RR (SVCPC) were more
oncogenic than virus strains with a complex RR (776) [16].
Susceptibility to tumor induction by SV40 is age-related in
hamsters. Tumors were not observed in the animals inoculated by
the intracardiac route in this study because those animals were
older at the time of virus exposure (Materials and Methods).
Tumors induced by WT and mutant viruses were characterized
for the content of SV40 DNA and for viral gene expression. The
Table 5. Persistent infections at day 270 in hamster liver and kidney by SV40 wild-type strains and microRNA mutants.
Virus Encode SV40 microRNA Day 270 viral loads (SV40 DNA copies/10
6 cells)a,b
Liver Kidney
776-WT + 11 181
776-SM1 0 Und 385
SVCPC-WT + 12 210
SVCPC-SM2 0 22 1116
SV40, simian virus 40; Und, undetectable.
aValues represent the average of normalized viral DNA copies/106 cells. The numbers of animals tested (6–9 each per virus and tissue) and those found to be virus-
positive (0–8 each) are shown in Table 1.
bThe following comparisons were statistically significant by the Wilcoxon rank-sum test at p#0.05: SVCPC-SM2 vs. SVCPC-WT in both liver and kidney, SVCPC-SM2 vs.
776-SM1 in both liver and kidney, and 776-WT vs. 776-SM1 in liver.
doi:10.1371/journal.ppat.1003912.t005
Figure 3. Effects of simian virus 40 microRNA and regulatory
region structure on relative viral loads in hamster tissues over
time. (A) Liver. (B) Kidney. Bars represent ratios of viral loads for the
comparisons listed below each set. Individual bars within each set
reflect days 3 to 270. Ratios were calculated using means of normalized
viral load data. (No bars are shown for day 270 in the liver for the two
ratios involving 776-SM1 as no virus was detected in the livers of
infected animals at that time point.) Numbers of animals analyzed are
shown in Table 1. Note the marked increases of the microRNA mutants
compared to wild-type viruses in both tissues.
doi:10.1371/journal.ppat.1003912.g003
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following tumor-associated SV40 DNA levels were determined by
RQ-PCR [copies/cell, mean (range)]: SVCPC-776= 32 (1–50) [5
tumors], SVCPC-776-SM1=14 (1–48) [5 tumors]; SVCPC=15
(1–23) [3 tumors], and SVCPC-SM2=10 (6–14) [4 tumors]. Tests
were not carried out to determine the integrated or episomal status
of those genome copies in the tumor cells. Total RNA was isolated
from the same tumors, reverse transcribed, and SV40 transcripts
quantitated by RQ-PCR (Figure 4). Results are expressed as the
number of SV40 transcripts per 106 copies of 18S ribosomal RNA
(GenBank accession No. X03205.1). Both early and late viral
mRNAs were detected in the tumors, with the SV40 early mRNAs
being more abundant than the late mRNAs.
Antibody responses to SV40 T-ag as well as neutralizing
antibody responses to SV40 were measured as described in
Materials and Methods (Table 9). All but one of the 33 tumor-
bearing animals (97%) produced T-antibodies with similar median
titers. Similarly, all (100%) of the tumor-bearing animals produced
SV40 neutralizing antibody with comparable neutralization titers,
regardless of the virus strain inoculated. Results were more
variable among the 70 animals that failed to develop tumors. The
frequency of T-antibody responses in tumor-free animals ranged
from 0% to 72% per group with median titers that tended to be
lower than those in animals with tumors. Animals exposed to the
2E viruses (776) tended to produce T-antibody more frequently
than those exposed to the 1E (SVCPC) viruses. There were no
discernible differences in patterns of T-antibody responses in
tumor-free animals related to the inoculation of miRNA-positive
or -negative viruses. Those responses indicate there was sustained
T-ag expression in the animals adequate to induce the production
of stable T-antibodies. From 42% to 80% of a given group
produced neutralizing antibody with median titers that tended to
be lower than those in the tumor-bearing animals in the same
group.
Discussion
One goal of this study was to identify tissues susceptible to SV40
infection and those that became persistently infected. Hamster
Table 6. SV40 mRNA expression in hamster liver and kidney tissues.
Virus Encode SV40 microRNA Days p.i. mRNA copies/10
6 vimentin copiesa
T-ag (early) VP1 (late)
Liver Kidney Liver Kidney
776-2E + 3 2784 Und 186 Und
7 1673 216 118 Und
45 484 135 Und Und
776-SM1 0 3 9329 Und 319 Und
7 2681 63 129 Und
45 7337 67 163 Und
SVCPC-WT + 3 8708 71 476 Und
14 19,628 38 651 Und
45 2331 147 Und 34
SVCPC-SM2 0 3 1851 59 239 Und
14 15,418 179 903 19
45 4450 237 229 38
SV40, simian virus 40; p.i., postinoculation; Und, undetectable.
aNumbers represent the average of observed viral transcript results from the tissues from two different animals analyzed at each time point. The relative expression of
vimentin mRNA copies (used to normalize viral expression) was about 3-fold higher in kidney samples as compared to those from liver.
doi:10.1371/journal.ppat.1003912.t006
Table 7. Transformation of primary mouse embryo fibroblasts by SV40 parental and microRNA-negative viruses.
Virus Encode SV40 microRNA Relative no. of transformed foci (%)
a
3 weeks 5 weeks
776-WT + 76 100
776-SM1 0 12 48
SVCPC-776-WT + 55 100
SVCPC-776-SM1 0 20 53
SVCPC-WT + 21 100
SVCPC-SM2 0 3 16
SV40, simian virus 40.
aReplicate plates (n = 4–6) were harvested per virus at each time point. Numbers of transformed foci per 16105 cells infected by each virus were normalized to the value
for the WT strain of each pair of viruses at 5 weeks, which was set as 100%. The overall transformation frequency was ,0.05%.
doi:10.1371/journal.ppat.1003912.t007
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liver, kidney, and spleen samples were frequently viral DNA
positive through day 45 p.i.; lung and brain tissues were less often
virus positive and muscle specimens were consistently virus
negative (Table 1). Higher viral loads (SV40 DNA copies/104
cells) were routinely detected in liver and kidney samples as
compared to other tissues, with virus titers in the liver often
exceeding those in the kidney during the early phases of infection
(Table 2, Figure 1, Figure 2). These results show that tissues varied
in their susceptibility to infection by SV40. Both SV40 miRNA in
WT infections and viral transcripts were detected in liver and
kidney samples (Tables 4 and 6), evidence of viral gene expression
in infected cells. Most kidney samples were virus-positive through
day 270, whereas liver tissues remained infected in most animals
for as long as 45 days p.i. and in some animals as late as day 270. It
is possible that livers are an unrecognized site of polyomavirus
persistence and it will be important in future studies to identify the
target cells in the liver that support long-term SV40 infections.
Evidence suggests that polyomaviruses can be transmitted by the
fecal/urine–oral route and can be found in lymphoid-rich samples
from hamsters and humans, so cells in the gastrointestinal tract
and in lymphoid tissues are of interest as well [2,12,14,21–26]
(Tables 1, 2). Results from an earlier study of SV40 vertical
transmission in hamsters are compatible with the tissue suscepti-
bilities described here [15]. In that investigation pregnant hamsters
were inoculated intraperitoneally with 16107 PFU of SV40 strains
and were sacrificed at different times up to 24 days p.i. Kidney and
spleen were infected in all 16 maternal animals, and lung in some
animals, confirming that cells in these tissues are susceptible to
infection by SV40.
Viral miRNAs have been discovered for several virus families,
including the herpesviruses and the polyomaviruses [19,20,27–33].
The functions of many of the viral miRNAs have not yet been
determined but are proposed to be involved in prolonging the
viability of infected cells and in promoting immune evasion to
increase virus survival [19,30,31,34]. Viral miRNA effects are
likely to be of significance to the establishment, maintenance, and/
or reactivation of persistent infections in susceptible hosts by
viruses that commonly establish chronic infections. Very few
studies have examined the effect of viral encoded miRNAs on viral
infection in an intact host. This study provides the first evidence to
our knowledge of the detectable expression and functional effects
of SV40 miRNAs on polyomavirus SV40 acute and persistent
infections in vivo in a susceptible host. Hamsters infected with SV40
mutants unable to express the viral miRNAs frequently contained
higher levels of viral DNA in liver and kidney tissues than animals
exposed to the WT viruses. This finding is compatible with the
original report that SV40 miRNAs reduce the expression of SV40
T-ag in infected cells [20], as higher levels of T-ag in mutant-
infected cells could be expected to support enhanced viral DNA
replication.
Table 8. Lack of effect of SV40 microRNA on tumor development in Syrian golden hamsters following intraperitoneal inoculation.
Virus Encode SV40 microRNA No. tumors/no. animals (%) p valuea
Time to tumors, weeks
Median (range) p valuea
776-WT + 2/20 (10) 0.27 34 (29–39) 0.67
776-SM1 0 1/20 (5) 34
SVCPC-776-WT + 8/13 (62) 0.14 28 (21–33) 0.26
SVCPC-776-SM1 0 10/20 (50) 33 (24–51)
SVCPC-WT + 4/10 (40) 0.50 26 (21–43) 0.83
SVCPC-SM2 0 8/20 (40) 33 (21–49)
Control cell lysate 0 0/10 (0) –
SV40, simian virus 40.
ap values for comparisons of % tumors and of time to tumors were determined by the Z test and the proportional hazards regression test, respectively.
doi:10.1371/journal.ppat.1003912.t008
Figure 4. Detection of simian virus 40 (SV40) early and late mRNAs in hamster tumors induced by wild-type viruses and microRNA-
negative mutants following intraperitoneal inoculation. SV40 transcripts in hamster tumors induced by wild-type and microRNA-negative
viral strains were reverse transcribed, quantitated by real-time quantitative polymerase chain reaction and expressed as the average number of SV40
mRNA copies per 106 copies of 18S ribosomal RNA. The numbers of tumors analyzed for each viral system were the following: SVCPC-776= 5, SVCPC-
776-SM1= 5, SVCPC= 3, and SVCPC-SM2=4. The error bars represent the standard deviation.
doi:10.1371/journal.ppat.1003912.g004
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SV40 strains tested in this study differed in the structures of
their RR. Variants with a duplication of the enhancer element in
the RR (i.e., complex RR) can replicate to somewhat higher levels
(,2-fold) in DNA replication assays and in cell cultures than
variants with a simple RR [35,36]. It has also been shown that
overexpression of T-ag stimulates replication of human JCV and
BKV isolates with simple RR in vitro [37]. In the current study, the
SV40 776 strains with complex RR exhibited approximately 2- to
5-fold higher viral loads in hamster kidney than the SVCPC
strains with simple RR (Figure 3B), suggesting an RR effect on
virus replication in vivo in kidney cells. A complex RR would likely
have a more pronounced enhancement on virus replication in
immunocompromised hosts. It has been observed that natural
SV40 variants with rearranged RR arise de novo in infected
immunocompromised rhesus monkeys [38] and this same
phenomenon has been observed with human polyomaviruses.
JCV isolates with a simple RR are shed in the urine, whereas
isolates with a complex RR are recovered from the brain and
cerebrospinal fluid of patients with progressive multifocal leuko-
encephalopathy [39–41]. The emergence of BKV with a
rearranged RR is linked to increased viral replication and
increased BKV-associated nephropathy disease in kidney trans-
plant recipients [42].
Notably, our results showed that the loss of viral miRNA had a
greater effect on viral DNA loads than that of the complex RR
structure. However, the absence of viral miRNA resulted in a
relatively larger increase of viral DNA in the 776 system than it did
with the SVCPC strain (Figure 3). We speculate that this stronger
effect might reflect the combination of the complex viral RR and
the absence of viral miRNA. Another virus distinction is that there
are several nucleotide differences between strains 776-WT and
SVCPC-WT in the T-ag gene, plus a 9-bp insertion in the SVCPC
gene, changes which result in 6 amino acid differences between the
two T-ags (Figure S1) [43,44]. However, we do not believe these
changes affected the level of viral DNA in hamster tissues. We
compared the average titers of virus stocks of 776-WT (n= 18) and
SVCPC-WT (n= 15) prepared in our laboratory at different times
over the last decade. There was no statistical difference (p.0.05)
between the groups, indicating no obvious differential T-ag effects
on virus replication.
SV40 miRNA was detected (Table 4) when levels of SV40 late
transcripts were low (Table 6) and infectious virus was not
recovered. This raises the question of how functional SV40
miRNAs were expressed in the absence of abundant lytic
infections of hamster cells. The most likely explanation is that
some cells in a given tissue were supporting complete cycles of
virus replication and the late transcription in those cells produced
adequate amounts of miRNA to yield the observed results.
Alternatively, it has been speculated there may be a mechanism to
produce miRNAs in polyomavirus chronically infected cells that is
not dependent on late viral gene expression [19]. Importantly, it
has been shown recently that BKV miRNA is expressed in BKV-
infected cultured cells before the onset of viral DNA replication
[45]. The BKV study observed increased replication of miRNA-
null mutants with an archetypal RR in renal proximal tubule
epithelial cells, similar to our findings with SV40 in hamsters.
However, the absence of BKV miRNA had no stimulatory effect
on replication of BKV variants with a rearranged RR, in contrast
to our SV40 results [45]. Whether this reflects a fundamental
difference between BKV and SV40, the influence of cell culture vs.
in vivo conditions, or some other experimental variable is a topic for
future study.
It has been proposed that SV40 miRNA may function to
mediate evasion of the host response to infected cells [20].
However, in this study the mutant viral loads were not reduced
more quickly than those of WT viruses over the first 45 days,
suggesting that mutant virus-infected cells were not cleared more
quickly by the host immune response (Figure 2). There was a
statistically significant difference between 776-WT and 776-SM1
in the number of animals that retained viral DNA in the liver at
Table 9. Antibody responses in tumor-bearing and tumor-free hamsters inoculated intraperitoneally with wild-type SV40 and
microRNA-negative virus mutants.
Virus
Encode SV40
microRNA
Tumor
bearing SV40 T-antibody
SV40 neutralizing
antibody
No. pos./No.
tested (%) Titer Median (range) No. pos./no. tested (%) Titer Median (range)
776-WT + + 2/2 (100) 100/1000 2/2 (100) 2000 (2000)
0a 13/18 (72) 100 (10–1000) 13/18 (72) 200 (20–2000)
776-SM1 0 + 1/1 (100) 1000 1/1 (100) 2000
0 12/19 (63) 100 (5–1000) 12/19 (63) 200 (20–2000)
SVCPC-776 + + 8/8 (100) 1000 (100–1000) 8/8 (100) 10,000 (2000–100,000)
0a 0/5 (0) – 3/5 (60) 200 (20–200)
SVCPC-776-SM1 0 + 9/10 (90) 100 (10–5000) 10/10 (100) 2000 (200–100,000)
0 7/10 (70) 10 (10–100) 8/10 (80) 20 (20–200)
SVCPC-WT + + 4/4 (100) 100 (100–5000) 4/4 (100) 200 (200–10,000)
0 3/6 (50) 10 (10) 4/6 (67) 20 (20–200)
SVCPC-SM2 0 + 8/8 (100) 100 (100–5000) 8/8 (100) 200 (200–40,000)
0 3/12 (25) 100 (10–100) 5/12 (42) 20 (20–200)
Controls (no virus) 0 0 0/10 (0) — 0/10 (0) —
SV40, simian virus 40.
aFrom reference [10].
doi:10.1371/journal.ppat.1003912.t009
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day 270, but not between SVCPC-WT and SVCPC-SM2. There
are several possible explanations for the inability to detect
pronounced miRNA effects on viral clearance. One possibility is
that the original model does not encompass the most important
role for the miRNA during infections. Perhaps SV40 has an
unrecognized non-miRNA mechanism for interfering with the
host immune response to allow establishment of chronic infections,
making the presence or absence of viral miRNAs irrelevant.
Another possibility is that the SV40 miRNAs may have been
unable to target a cellular mRNA critical to the host response
because of sequence mismatches between the primate virus and
the hamster genome. (It has been proposed that human JCV and
BKV miRNAs target a stress-induced human cell ligand
recognized by natural killer cells to mediate killing of virus-
infected cells [46].) Alternatively, the Syrian golden hamster
immune system may possess some unusual characteristic that
makes the animals prone to establishment of persistent infections
by microbial agents, thereby over-riding or negating possible
miRNA effects. For example, hamsters are known to be
susceptible to infections by numerous viruses and a parasite able
to infect humans [47–56]. Finally, although viral miRNA
expression was detected and differences were observed in viral
loads between the WT and viral miRNA mutant viruses in
hamster tissues, perhaps the levels of the viral miRNAs were
insufficient to mediate effects on viral clearance. Because of these
unknown factors, we cannot conclude that the viral miRNA never
affects the host immune response. It is noteworthy that our
findings are similar to the observation that a miRNA-negative
mutant of murine polyomavirus generally behaved like the WT
virus in experimentally infected mice with respect to viral
clearance and cellular immunity. Although expression of miRNAs
was not directly demonstrated, the genome copy loads of the
mutant tended to exceed those of the WT polyomavirus in adult
mouse kidneys [29].
There are several limitations to this study. Hamsters are not the
natural host for SV40, but they represent one of the few systems
that can be used for investigations of polyomavirus infections in
intact animals. The intracardiac route of inoculation that was used
to allow determination of the breadth of susceptible tissues and the
sites of viral persistence was not the natural route of infection. It
was beyond the scope of this study to compare different routes of
inoculation. In addition, the dose of virus inoculated was high
compared to the low level of virus encountered in a natural
infection. It is conceivable that the nonnatural route of inoculation
coupled with the high level of inoculum might have masked
possible phenotypes. The virus did not appear to produce
infectious progeny beyond the early stages of infection, although
it is possible that additional tests of more tissue samples might have
detected extended replication. Alternatively, it is possible that
SV40 enters a persistent, nonproductive state relatively soon after
infection.
The study raised several challenging subjects for follow-up
investigations. These include a potential role of viral miRNA in
reactivation of SV40 persistent infections, the molecular basis for
the difference between viral miRNA inhibitory effects on BKV
and SV40 viruses with complex RR, the mechanism of expression
of SV40 miRNA in the absence of abundant viral replication, and
the interaction of SV40 with susceptible cells in the liver.
In summary, this study demonstrated for the first time that
SV40 miRNAs are expressed and are functional in vivo in infected
hamsters. We showed that SV40 has a broad tissue tropism,
identified tissues that support viral DNA replication (kidney, liver,
spleen, lung and brain), and found that kidneys are the major site
for long-term persistence with livers a possible secondary site. One
role for the miRNA appears to be to reduce viral loads in infected
tissues. We also showed that viral miRNA does not appear to affect
SV40 tumorigenicity in hamsters, the traditional assay for SV40
oncogenic potential.
Materials and Methods
Ethics statement
Outbred Syrian golden hamsters (M. auratus) were obtained
from Harlan Laboratories and were housed in the biohazard
facility in the Center for Comparative Medicine at Baylor College
of Medicine. The animals were maintained in accordance with
established national guidelines as outlined in the Guide for the
Care and Use of Animals [57] and the Animal Welfare Act. The
Center for Comparative Medicine is fully accredited by the
Association for Assessment and Accreditation of Laboratory
Animal Care International (Animal Welfare Assurance Number
A3823-01). The studies were approved (Protocol Number AN668)
by the Institutional Animal Care and Use Committee of Baylor
College of Medicine.
Animal experiments
Procedures for intracardiac and intraperitoneal injections have
been described [10,16]. We have excellent survival outcomes ($
99%) with both routes of inoculation. Five- to 7-week-old female
hamsters were used for intracardiac inoculations for the patho-
genesis studies, whereas 3-week-old male and female hamsters
were employed for intraperitoneal injections for the tumorigenicity
studies. Animals were inoculated with 16107 PFU of virus in
0.1 ml by the intracardiac route or 16107 PFU of virus in 0.5 ml
intraperitoneally. Control animals were inoculated with uninfected
cell lysate under the same conditions. Animals were sacrificed at
designated days p.i., at evidence of neoplasia or debility, or at the
termination of experiments. Euthanasia involved isoflurane
overdose and exsanguination by cardiac puncture. Necropsies
were carried out on all the animals inoculated by the intracardiac
route and some of those inoculated by the intraperitoneal route.
Tissue samples were collected and were stored frozen or preserved
in RNAlater.
Viruses
Two natural SV40 strains from different phylogenetic groups
were studied [43]. Reference strain 776 (complex RR) was isolated
from an adenovirus type 1 vaccine seed stock [58]. SVCPC (simple
RR) was recovered from a pediatric brain tumor [59]; the same
virus has been detected in other human cancers [21,59–61] and in
the Russian oral poliovaccine [62]. The structures of the 776 and
SVCPC viral RR are shown in reference [15]. The miRNA-
negative mutant derived from 776-WT virus (776-SM1) was
obtained from C. Sullivan [20]. The construction of recombinant
virus SVCPC-776-WT was described previously [16]. This
recombinant contains the RR, late region, the N-terminal part
of T-ag, and the small t-ag coding region of strain SVCPC with
the C-terminal part of T-ag (BstXI and BamHI restriction
fragment) from 776-WT. Recombinant SVCPC-776-SM1 was
constructed following the same strategy and contains the C-
terminal T-ag fragment from 776-SM1.
Due to nucleotide polymorphisms in the miRNA region, the
predicted sequence of the pre-miRNAs of SVCPC-WT and 776-
WT differ slightly. Consequently, the amino-acid sequences of the
T-ags of SVCPC-WT and 776-WT also slightly diverge. The
miRNA-negative mutant derived from SVCPC-WT virus (SVCPC-
SM2) was created by mutagenesis of 18 nucleotide positions in the
pre-miRNA region analogous to that of 776-SM1. These mutations
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disrupt the hairpin structure of the SVCPC-WT pre-miRNA on the
late strand while leaving intact the amino acid-coding potential of
T-ag on the early strand (Figure S1) [20]. Three overlapping
fragments covering the miRNA region were PCR-amplified with six
mutagenic primers using SVCPC-WT or 776-SM1 DNA as a
template. Three PCR primer sets were MA1 59-TTCCTGGG-
GATCCAGACATGATAAG-39 and MIRA2 59-CTCCGCAG-
CCTTCGCAGTCCT-39 on the SVCPC-WT template, MIRB1
59-AGGCTGCGGAGCTTGAAACGAAC-39 and MIRB2 59-A-
GCCAGGAAAATGCTGATAAAAATG-39 using the 776-SM1
template, and MIRC1 59-AGCATTTTCCTGGCTGCTGTCA-
TCATCA-39 and SVPST 59-AAAACACTGCAGGCCAGATT-
TG-39 on the SVCPC-WT template. Three mutated fragments
were subsequently joined together by overlapping PCR using outer
primers. The resulting mutated fragment was cleaved with
restriction enzymes PstI and BamHI and used to replace the
corresponding part of the genome of SVCPC-WT also cleaved with
the same restriction enzymes. The final miRNA-negative mutant
virus was denoted SVCPC-SM2.
Each recombinant construct was sequenced to confirm that no
accidental mutations had been introduced and was transfected
into TC-7 cells to confirm its infectivity. The mutant viruses were
shown to be defective for production of viral miRNAs using a test
designed to detect early mRNA cleavage fragments that are
generated by functional miRNA [20]. TC-7 cells were infected at a
multiplicity of infection of 2 PFU/cell with each virus and total
RNA was harvested at 65 hours p.i. using the RNAqueous-4 PCR
kit (Ambion) and treated with DNase I. Total RNA was Northern
blotted with a probe specific to the 39 region of SV40 early mRNA
(nucleotides 2681–2845, prepared by PCR), radiolabelled with
a32PdCTP using the DECAprimeII kit (Ambion). The character-
istic early mRNA 39 cleavage fragment about 260-nt in size was
generated by each of the three WT viruses (776-WT, SVCPC-
776-WT, and SVCPC-WT) that produce intact miRNAs. In
contrast, the miRNA-negative mutant viruses (776-SM1, SVCPC-
776-SM1, and SVCPC-SM2) produced only full-length early
transcripts without any detectable miRNA-generated 39 cleavage
fragment.
Virus stocks were prepared in TC-7 monkey kidney cells.
Infectious virus titers were determined by plaque assay [63]. The
numbers of viral genome copies in virus stocks were determined
using an RQ-PCR assay.
Nucleic acid extractions and PCR analysis
Small pieces of frozen tissues were minced and digested
overnight with Proteinase K and nuclei lysis solution. Proteins
were precipitated and removed and then the DNA was
precipitated with isopropanol, washed, resuspended in Tris-EDTA
buffer (pH 8.0), and stored at 220uC [16]. Two or three random
fragments from each tissue sample were processed and assayed
independently; those values were averaged to represent the results
from that tissue.
SV40 DNA was detected and quantified by an RQ-PCR assay
[64]. Five ml of DNA sample were assayed in a final reaction
volume of 25 ml using 40 cycles of amplification. The single-copy
hamster vimentin gene was measured by RQ-PCR to evaluate the
quality of each DNA extract and to normalize viral gene copy
numbers to cell numbers [15]. Vimentin copies per reaction were
divided by 2 to determine cell equivalents per reaction. A sample
was omitted from viral analysis if less than 10,000 cell equivalents
were amplified in a vimentin reaction. For those samples adequate
for further analysis, RQ-PCR reactions were considered virus
positive if $10 viral genome copies per reaction were detected.
Viral loads are expressed as SV40 DNA copies per 104 cells. Total
RNA was extracted from samples preserved in RNAlater (Ambion)
using the RNAqueous-4 PCR kit (Ambion) with DNase 1
treatment. RNA was reverse transcribed as described and then
quantitated by RQ-PCR [14]. As a control, vimentin RNA or 18S
ribosomal RNA was amplified and used to normalize SV40 RNA.
Data are expressed as mRNA copies per 106 vimentin molecules
(liver and kidney tissues) or copies per 106 18S molecules (hamster
tumors). Primer and probe sequences have been reported [14].
The number of SV40 genome copies per PFU varied among the
four virus stocks for unknown reasons: 776-WT, 1700 genome
copies/PFU; 776-SM1, 130 genome copies/PFU; SVCPC-WT,
1800 genome copies/PFU; and SVCPC-SM2, 590 genome
copies/PFU. To directly compare viral loads in hamster tissues
between virus strains (based on PCR assays which detect viral
DNA copies), adjustments were made to account for the different
number of viral genome copies in each 16107 PFU inoculum
given the hamsters. SV40 DNA levels determined by PCR for a
given sample were normalized by dividing the number of observed
SV40 DNA copies by the number of viral DNA copies (61029)
inoculated for that virus (i.e., if a viral load value was ‘‘X’’ copies of
SV40 DNA per 104 cells for an SVCPC-WT sample, ‘‘X’’ would
be adjusted by dividing by 18). Normalized values were used when
the dynamics of infection were compared between different
viruses. Observed (non-adjusted) viral load values were used for
analyses involving a single virus strain.
MicroRNA analysis
Portions of frozen livers and kidneys from infected or uninfected
hamsters were coded and assayed without knowledge of sample
identity. The samples were lysed in 1 mL of TRIzol reagent (Life
Technologies) containing Lysing Matrix B tissue grinding tubes
(MP Biomedicals) by subjecting the tubes to 3 cycles of a 1-minute
duration of tissue grinding at the maximum speed using a Mini-
Beadbeater-16 (Biospec Products) followed by 1 minute of cooling
on ice. The lysed samples were transferred individually to an
additional 4 mL of TRIzol followed by RNA isolation according
to the manufacturer’s standard protocol. To enrich for small RNA,
gel fractionation was performed. Total RNA was first subjected to
electrophoresis on a Tris-borate-EDTA-Urea-15% polyacryl-
amide gel. The gel portion between the bromophenol blue and
xylene cyanol markers (approximately 10–35 nucleotides) was
excised and then cut into smaller pieces. The gel pieces were
soaked in 15 mL of 1 M sodium chloride solution to allow RNA
elution overnight at 4uC, with gentle rocking. The eluted small
RNA supernatant was transferred to a Vivaspin 15R 2000
MWCO centrifugal concentrator (BioExpress) and spun at 3000
g until the supernatant was concentrated down to approximately
500 mL. The small RNAs were precipitated overnight at220uC in
one-tenth volume of 3 M sodium acetate, pH 5.2, and an equal
volume of isopropanol. The small RNA was reverse transcribed
using the manufacturer’s (Taqman, Life Technologies) primers
(designed to recognize the SV40 3p miRNA) and the SuperScript
III reverse transcriptase, using a modified version of the
manufacturer’s protocol: 16uC for 30 minutes, followed by 60
cycles of 30uC for 30 seconds, 42uC for 30 seconds, and 50uC for
1 second, and a final incubation at 85uC for 5 minutes. The
reverse transcription product was used in the Taqman Small RNA
assay for detection of the SV40 3p miRNA (Life Technologies) and
the assay was performed on a ViiA 7 real-time PCR system (Life
Technologies) according to the manufacturer’s protocol. The
linear range of the assay was determined using a dilution series of
total RNA (from SV40 776-infected BSC-40 cells at an MOI of
10) as the standard. This analysis revealed linearity down to CT
39. We also estimated the sensitivity of our assay. The total
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number of cells assayed was held constant at 300,000 while
altering the ratio of infected (776- infected BSC-40, MOI of 10) to
uninfected cells. This resulted in an estimate of sensitivity ranging
between 1 in 8,000 and 1 in 100,000 infected to uninfected cells.
To minimize the chances of false positives, a conservative cutoff of
CT 35 was chosen to score positive for miRNA detection. For
comparison, we also calculated the SV40 3p miRNA and miR-
Let7a (Taqman Life Technologies) levels in BSC40 African green
monkey cells infected with SV40 (strain 776, MOI 10) and
harvested RNA at 24 hours postinfection. The average of at least
three independent technical replicates was used to calculate CT for
all analyses.
Antibody assays
Antibody responses to SV40 T-ag were detected and titered by
indirect immunofluorescence as described [10]. SV40 neutralizing
antibodies were measured using a plaque-reduction assay in TC-7
cells [10].
Virus transformation
Focus-forming assays to quantitate SV40 transformation used
primary mouse embryo fibroblasts infected with different strains of
SV40 at 5 PFU/cell [16]. Replicate plates (usually 4–6) were
harvested at 3 and 5 weeks p.i. and the number of transformed foci
determined. For each WT and mutant virus pair, numbers of
transformed foci per 16105 cells infected were calculated as the
percentage of WT foci at 5 weeks (set as 100%). The transforming
frequencies overall were about 1 per 2000 infected cells.
Virus rescue
Tissue fragments were minced, frozen and thawed two times,
and the cell debris pelleted by centrifugation. The pellets were
resuspended in 200 ml buffer and both the lysate supernatants and
the lysate pellets were inoculated into TC-7 cell cultures. These
cultures were incubated for 12 days, at which time the samples
were harvested and assayed for infectious virus by plaque assay
[63].
Statistical analysis
Logarithm base 2 (log2 transformed) values were used for
evaluation of observed viral load data to reduce the effect of very
low or very high values which might bias the mean. Statistical
analysis indicated log normal distribution of the viral load data; the
two-sample T-test was used to determine the difference in
geometric means for adjusted viral loads between groups
according to viral strain. The Wilcoxon rank-sum test was used
to determine the difference in persistent infections at day 270 by
different viral strains. The Z test for the comparison of proportion
was used to evaluate differences in the frequency of tumor
formation between groups exposed to different viral strains and the
proportional hazards regression test to assess differences in survival
times of animals that developed tumors between groups. Statistical
analyses were performed using statistical software SAS version 9.3.
A p-value of #0.05 was considered statistically significant.
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